OmniAb, Inc. (OABIW) stock
OABIWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/309% above fair value
$0.41−0.01 (-2.38%)
Close on Oct 30, 2026Market cap $742.95MP/E –Yield –
OmniAb net income
Net income is the profit left for shareholders after every expense, interest and tax.
OmniAb's net income for the twelve months ending Sep 30, 2026 was -$43.47M. For fiscal 2025 it was -$64.78M. The highest annual figure on record is -$22.33M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$64.78M | – |
| FY2024 | Dec 31, 2024 | -$62.03M | – |
| FY2023 | Dec 31, 2023 | -$50.62M | – |
| FY2022 | Dec 31, 2022 | -$22.33M | – |
| FY2021 | Dec 31, 2021 | -$27.04M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$15.73M | – |
| Q2 FY2026 | Jun 30, 2026 | -$5.86M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.71M | – |
| Q4 FY2025 | Dec 31, 2025 | -$14.18M | – |
| Q3 FY2025 | Sep 30, 2025 | -$16.53M | – |
| Q2 FY2025 | Jun 30, 2025 | -$15.88M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$13.07M | – |
| Q3 FY2024 | Sep 30, 2024 | -$16.37M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$18.96M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.05M | -306.1% |
| Q3 FY2023 | Sep 30, 2023 | -$15.74M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.73M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.10M | – |
| Q4 FY2022 | Dec 31, 2022 | $6.82M | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.60M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.28M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.28M | – |
| Q3 FY2021 | Sep 30, 2021 | -$170.58K | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.19K | – |